Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1981 1
1982 1
1983 1
1984 2
1985 2
1986 2
1987 1
1988 2
1989 1
1990 1
1991 4
1992 2
1993 2
1994 4
1995 2
1996 2
1997 5
1998 4
1999 2
2001 4
2003 4
2004 3
2005 3
2006 2
2007 3
2008 5
2009 4
2010 4
2011 6
2012 4
2013 6
2014 7
2015 8
2016 5
2017 8
2018 11
2019 7
2020 9
2021 8
2022 4
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Locally Recurrent Anal Canal Squamous Cell Carcinoma"
Page 1
Anal Cancer: The Past, Present and Future.
Gondal TA, Chaudhary N, Bajwa H, Rauf A, Le D, Ahmed S. Gondal TA, et al. Curr Oncol. 2023 Mar 11;30(3):3232-3250. doi: 10.3390/curroncol30030246. Curr Oncol. 2023. PMID: 36975459 Free PMC article. Review.
Among anal cancer, squamous cell cancer is the most common malignancy. The incidence of all stages of anal squamous cell cancer has been increasing. Human papillomavirus infection and immunosuppression are major risk factors for anal …
Among anal cancer, squamous cell cancer is the most common malignancy. The incidence of all stages of anal sq …
Squamous cell carcinoma of the anal canal.
Morton M, Melnitchouk N, Bleday R. Morton M, et al. Curr Probl Cancer. 2018 Sep;42(5):486-492. doi: 10.1016/j.currproblcancer.2018.11.001. Epub 2018 Nov 23. Curr Probl Cancer. 2018. PMID: 30497849 Review.
Anal squamous cell carcinoma (SCC) is a rare cancer and accounts for approximately 4% of all cancers of the lower alimentary tract. ...Vaccines directed against oncogenic HPV serotypes exist, and their utility for preventing anal neoplasia is un …
Anal squamous cell carcinoma (SCC) is a rare cancer and accounts for approximately 4% of all cancers of the lowe …
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study.
Morris VK, Salem ME, Nimeiri H, Iqbal S, Singh P, Ciombor K, Polite B, Deming D, Chan E, Wade JL, Xiao L, Bekaii-Saab T, Vence L, Blando J, Mahvash A, Foo WC, Ohaji C, Pasia M, Bland G, Ohinata A, Rogers J, Mehdizadeh A, Banks K, Lanman R, Wolff RA, Streicher H, Allison J, Sharma P, Eng C. Morris VK, et al. Lancet Oncol. 2017 Apr;18(4):446-453. doi: 10.1016/S1470-2045(17)30104-3. Epub 2017 Feb 18. Lancet Oncol. 2017. PMID: 28223062 Free PMC article. Clinical Trial.
BACKGROUND: Squamous cell carcinoma of the anal canal (SCCA) is a rare malignancy associated with infection by human papillomavirus (HPV). ...FUNDING: National Cancer Institute/Cancer Therapy Evaluation Program, the HPV and Anal Cancer Fo …
BACKGROUND: Squamous cell carcinoma of the anal canal (SCCA) is a rare malignancy associated with infecti …
Locally Recurrent Disease Related to Anal Canal Cancers.
Sammour T, Rodriguez-Bigas MA, Skibber JM. Sammour T, et al. Surg Oncol Clin N Am. 2017 Jan;26(1):115-125. doi: 10.1016/j.soc.2016.07.006. Surg Oncol Clin N Am. 2017. PMID: 27889030 Review.
Surgery for anal cancer is usually reserved for patients with persistent disease or local recurrence after definitive chemoradiation therapy. Patients with local recurrence should be re-evaluated for evidence of metastatic disease using positron …
Surgery for anal cancer is usually reserved for patients with persistent disease or local recurrence after definitive c …
Definitive chemoradiation in nonmetastatic squamous cell carcinoma anal canal: A single-institution experience.
Kumar V, Bansal S, Badola A, Nautiyal V, Gupta M, Ahmad M, Saini S. Kumar V, et al. J Cancer Res Ther. 2022 Dec;18(Supplement):S405-S409. doi: 10.4103/jcrt.JCRT_979_20. J Cancer Res Ther. 2022. PMID: 36510995 Free article.
PURPOSE: The purpose of the study was to analyze the survival outcomes and toxicities in squamous cell carcinoma anal canal treated with definitive chemoradiotherapy. MATERIALS AND METHODS: Retrospective analysis of 51 patients with squamous …
PURPOSE: The purpose of the study was to analyze the survival outcomes and toxicities in squamous cell carcinoma ana …
Anal squamous cell carcinoma: are we improving outcomes?
Mackowski A, Levitt M, Makin G, Salama P, Tan P, Penter C, Platell C. Mackowski A, et al. ANZ J Surg. 2018 Oct;88(10):1013-1016. doi: 10.1111/ans.14745. Epub 2018 Aug 29. ANZ J Surg. 2018. PMID: 30159994
BACKGROUND: Anal squamous cell carcinoma (SCC) is a rare malignancy. The purpose of this study was to review a single institution's experience. ...CONCLUSION: CRT is a proven and reasonable effective approach in managing anal cancer. Observed …
BACKGROUND: Anal squamous cell carcinoma (SCC) is a rare malignancy. The purpose of this study was to review a s …
Experimental and investigational drugs for the treatment of anal cancer.
Jacome AA, Eng C. Jacome AA, et al. Expert Opin Investig Drugs. 2018 Dec;27(12):941-950. doi: 10.1080/13543784.2018.1543659. Epub 2018 Nov 8. Expert Opin Investig Drugs. 2018. PMID: 30381968 Review.
INTRODUCTION: Squamous cell carcinoma of the anal canal (SCCA) is a rare malignancy, but its incidence rates have been increasing in the last decade. ...The potential high rates of recurrence after standard chemoradiotherapy for locall …
INTRODUCTION: Squamous cell carcinoma of the anal canal (SCCA) is a rare malignancy, but its incidence ra …
Treatment of the Primary Tumor in Anal Canal Cancers.
Glynne-Jones R, Rao S. Glynne-Jones R, et al. Surg Oncol Clin N Am. 2017 Jan;26(1):73-90. doi: 10.1016/j.soc.2016.07.003. Surg Oncol Clin N Am. 2017. PMID: 27889038 Review.
Radical concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C (MMC) remains the standard of care for squamous cell carcinoma of the anus. Phase III trials over 2 decades have used combined radiation doses of 50 to 60 Gy with concurrent fluoropyrimi …
Radical concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C (MMC) remains the standard of care for squamous cell …
Squamous cell carcinoma of the anal margin treated with radiotherapy.
Mendenhall WM, Zlotecki RA, Vauthey JN, Copeland EM 3rd. Mendenhall WM, et al. Surg Oncol. 1996 Feb;5(1):29-35. Surg Oncol. 1996. PMID: 8837302 Review.
Squamous cell carcinoma of the anal margin is relatively rare. We present a series of patients treated with radiotherapy alone or combined with concomitant chemotherapy at our institution and review the pertinent literature. Ten patients with AJCC T2N0 …
Squamous cell carcinoma of the anal margin is relatively rare. We present a series of patients treated with radi …
Outcome following local excision of T1 anal cancers-a systematic review.
Pedersen TB, Kildsig J, Serup-Hansen E, Gocht-Jensen P, Klein MF. Pedersen TB, et al. Int J Colorectal Dis. 2020 Sep;35(9):1663-1671. doi: 10.1007/s00384-020-03687-8. Epub 2020 Jul 15. Int J Colorectal Dis. 2020. PMID: 32671458 Review.
PURPOSE: In most cases, squamous cell carcinoma of the anus (SCCA) is treated with chemo-radiotherapy preserving sphincter function and offering good long-term survival and low recurrence rates. ...Recurrence rates are high. Therefore, a thoroug …
PURPOSE: In most cases, squamous cell carcinoma of the anus (SCCA) is treated with chemo-radiotherapy preserving sphinc …
152 results